Breathe Well Live Well
|
Sweden says AstraZeneca used questionable asthma drug API from Indian plant
FiercePharma Manufacturing AstraZeneca ($AZN) said last week it was closing a plant in India that made the API for asthma drugs, noting there is not much demand any longer for the terbutaline sulfate it makes. But what the U.K. company did not say was that before its closing … |
View full post on asthma – Google News
Economic Times |
Cipla Ltd launches copy of GSK's top asthma drug in Germany, Sweden
Economic Times MUMBAI: Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will be marketed under … |
View full post on asthma – Google News
Economic Times |
India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden
Reuters MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will … Cipla targets US with asthma, HIV drugs |
View full post on asthma – Google News
Economic Times |
India's Cipla Launches Copy Of GSK's Top Asthma Drug In Germany, Sweden
Business Insider MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will … Cipla launches Serroflo in Germany and Sweden with affordable high quality … |
View full post on asthma – Google News
|
Sweden approves copy of GSK asthma blockbuster
FiercePharma Swedish regulators have approved a knock-off version of the asthma drug, which brought in more than $8 billion in 2010 sales for GSK, paving the way for it to be sold in Germany, Italy, Portugal, Hungary and the Czech and Slovak Republics, … Glaxo's Advair Faces Sales Decline on Swedish Generic Approval Glaxo's Advair Faces Sales Decline on Swedish Generic Approval |
View full post on asthma – Google News